Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID

Overview

Journal J Med Virol

Specialty Microbiology

Date 2025 Mar 3

PMID 40025839

Authors

Kristoffer Skaalum Hansen

Sofie Eg Jorgensen

Cagla Comert

Berit Schiottz-Christensen

Peter Bross

Jane Agergaard

Steffen Leth

Lars Ostergaard

Johan Palmfeldt

Rikke Katrine Jentoft Olsen

Trine H Mogensen

Affiliations

Soon will be listed here.

Abstract

Long COVID represents a significant global health challenge with an unclear etiology. Alongside accumulating evidence of mitochondrial dysfunction in patients with acute SARS-CoV-2 infection, a symptomatic overlap exists between long COVID and mitochondrial disorders. However, the genetic underpinnings of mitochondrial dysfunction in long COVID have not been previously explored. We employed whole genome sequencing to analyze 13 patients with severe long COVID to identify genetic defects related to mitochondrial function. We performed extracellular bioenergetics flux analysis on peripheral blood mononuclear cells and proteomics to evaluate cellular bioenergetics and compared the results to those of healthy controls. Our investigation identified 10 variants classified as pathogenic or likely pathogenic and 83 variants of unknown significance affecting a wide range of mitochondria-associated biological functions. Bioenergetics flux analysis in peripheral blood mononuclear cells revealed an altered ATP production rate in four long COVID patients compared to healthy controls. This study presents initial evidence of a potential underlying genetic predisposition to mitochondrial dysfunction in long COVID while demonstrating altered cellular energy capacity in a subset of these patients. These findings open avenues for further research into the role of mitochondrial dysfunction and pathology in patients suffering from long COVID and may pave the way for targeted therapeutic strategies aimed at mitigating mitochondrial dysfunction.

References

Georgieva E, Ananiev J, Yovchev Y, Arabadzhiev G, Abrashev H, Abrasheva D . COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int J Mol Sci. 2023; 24(19). PMC: 10573237. DOI: 10.3390/ijms241914876. View

Ajaz S, McPhail M, Singh K, Mujib S, Trovato F, Napoli S . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. 2020; 320(1):C57-C65. PMC: 7816428. DOI: 10.1152/ajpcell.00426.2020. View

Zhang Q, Bastard P, Cobat A, Casanova J . Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022; 603(7902):587-598. PMC: 8957595. DOI: 10.1038/s41586-022-04447-0. View

Kaminski M, Roth D, Sass S, Sauer S, Krammer P, Gulow K . Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death. Biochim Biophys Acta. 2012; 1823(5):1041-52. DOI: 10.1016/j.bbamcr.2012.03.003. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Taylor K, Pearson M, Das S, Sardell J, Chocian K, Gardner S . Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis. J Transl Med. 2023; 21(1):775. PMC: 10621206. DOI: 10.1186/s12967-023-04588-4. View

Vockley J, Dobrowolski S, Arnold G, Bonilla Guerrero R, Derks T, Weinstein D . Complex patterns of inheritance, including synergistic heterozygosity, in inborn errors of metabolism: Implications for precision medicine driven diagnosis and treatment. Mol Genet Metab. 2019; 128(1-2):1-9. PMC: 8931500. DOI: 10.1016/j.ymgme.2019.07.011. View

Balnis J, Madrid A, Drake L, Vancavage R, Tiwari A, Patel V . Blood DNA methylation in post-acute sequelae of COVID-19 (PASC): a prospective cohort study. EBioMedicine. 2024; 106:105251. PMC: 11286994. DOI: 10.1016/j.ebiom.2024.105251. View

Jensen M, Jensen C, Gudex C, Pedersen K, Sorensen S, Ehlers L . Danish population health measured by the EQ-5D-5L. Scand J Public Health. 2021; 51(2):241-249. PMC: 9969307. DOI: 10.1177/14034948211058060. View

10.

Hansen K, Mogensen T, Agergaard J, Schiottz-Christensen B, Ostergaard L, Vibholm L . High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2022; 24:100539. PMC: 9627534. DOI: 10.1016/j.lanepe.2022.100539. View

11.

Sherman B, Hao M, Qiu J, Jiao X, Baseler M, Lane H . DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50(W1):W216-W221. PMC: 9252805. DOI: 10.1093/nar/gkac194. View

12.

Sercel A, Sturm G, Gallagher D, St-Onge M, Kempes C, Pontzer H . Hypermetabolism and energetic constraints in mitochondrial disorders. Nat Metab. 2024; 6(2):192-195. DOI: 10.1038/s42255-023-00968-8. View

13.

Kumari D, Singh Y, Singh S, Dogra V, Srivastava A, Srivastava S . "Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity". J Med Virol. 2023; 95(2):e28553. DOI: 10.1002/jmv.28553. View

14.

Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham T . MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2020; 49(D1):D1541-D1547. PMC: 7778944. DOI: 10.1093/nar/gkaa1011. View

15.

Brodin P, Casari G, Townsend L, OFarrelly C, Tancevski I, Loffler-Ragg J . Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022; 28(5):879-882. DOI: 10.1038/s41591-022-01766-7. View

16.

Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J . Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020; 370(6515). PMC: 7857407. DOI: 10.1126/science.abd4570. View

17.

Kapnick S, Pacheco S, McGuire P . The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism. Metabolism. 2017; 81:97-112. PMC: 5866745. DOI: 10.1016/j.metabol.2017.11.010. View

18.

Vo T, Godard P, de Saint-Hubert M, Morrhaye G, Swine C, Geenen V . Transcriptomic biomarkers of the response of hospitalized geriatric patients with infectious diseases. Immun Ageing. 2010; 7:9. PMC: 2933667. DOI: 10.1186/1742-4933-7-9. View

19.

Mosegaard S, Twayana K, Denis S, Kroon J, Schomakers B, van Weeghel M . Human inborn errors of long-chain fatty acid oxidation show impaired inflammatory responses to TLR4-ligand LPS. FASEB Bioadv. 2024; 6(9):337-350. PMC: 11467727. DOI: 10.1096/fba.2024-00060. View

20.

. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023; 621(7977):E7-E26. PMC: 10482689. DOI: 10.1038/s41586-023-06355-3. View